EP3444363
BIOMARKERS FOR PREDICITING AND ASSESSING RESPONSIVENESS OF THYROID AND KIDNEY CANCER SUBJECTS TO LENVATINIB COMPOUNDS
:
EP einkaleyfi: Þýðing ekki lögð inn:
31.5.2012:
25.11.2020:
18197141.7
:
30.5.2032
:
BIOMARKERS FOR PREDICITING AND ASSESSING RESPONSIVENESS OF THYROID AND KIDNEY CANCER SUBJECTS TO LENVATINIB COMPOUNDS
31.5.2012
25.11.2020
:
Eisai R&D Management Co., Ltd.:
6-10 Koishikawa, 4-Chome Bunkyo-Ku, Tokyo 112-8088, JP
:
Funahashi, Yasuhiro:
Ibaraki, 300-2635, JP
:
Kadowaki, Tadashi:
Ibaraki, 300-2635, JP
:
Matsui, Junji:
Ibaraki, 300-2635, JP
:
Simon, Jason S.:
Woodcliff Lake, NJ 07677, US
:
XU, Lucy:
Woodcliff Lake, NJ 07677, US
:
201161493294 P:
3.6.2011:
US
:
C12Q 1/6886, G01N 33/574